1 |
Hanash SM, Baik CS, Kallioniemi O (2011). Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol, 8, 142-50.
DOI
ScienceOn
|
2 |
Gray J, Chattopadhyay D, Beale GS, et al (2009). A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer, 9, 271.
DOI
ScienceOn
|
3 |
Gstaiger M, Aebersold R (2009). Applying mass spectrometrybased proteomics to genetics, genomics and network biology. Nat Rev Genet, 10, 617-27.
DOI
ScienceOn
|
4 |
Hainaut P, Plymoth A (2011). Biomarkers in cancer research and treatment: promises and challenges. Curr Opin Oncol, 23, 61.
DOI
ScienceOn
|
5 |
Hanash SM, Pitteri SJ, Faca VM (2008). Mining the plasma proteome for cancer biomarkers. Nature, 452, 571-9.
DOI
ScienceOn
|
6 |
Hatakeyama H, Kondo T, et al (2006). Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics, 6, 6300-16.
DOI
ScienceOn
|
7 |
Hooshmand S, Ghaderi A, Yusoff K, et al (2013). Downregulation of RhoGDI increased migration and invasion of ER+MCF7 and ER? MDA-MB-231 breast cancer cells. Cell Adh Migr, 7, 297-303.
DOI
ScienceOn
|
8 |
International Cancer Genome Consortium, Hudson TJ, Anderson W, et al (2010). International network of cancer genome projects. Nature, 464, 993-8.
DOI
ScienceOn
|
9 |
IBM Corp. Released 2011. IBM SPSS Statistics for Windows, V. A., NY: IBM Corp.
|
10 |
Jacquemier J, Ginestier C, Rougemount J, et al (2005). Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res, 65, 767-79.
|
11 |
Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
DOI
ScienceOn
|
12 |
Edwards BK, Ward E, Kohler BA, et al (2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 116, 544-73.
DOI
ScienceOn
|
13 |
Etzioni R, Urban N, Ramsey S, et al (2003). The case for early detection. Nat Rev Cancer, 3, 243-52.
DOI
ScienceOn
|
14 |
Ghabaee M, Bayati A, Amir Saroukolaei, et al (2009). Analysis of HLA DR2&DQ6 (DRB1* 1501, DQA1* 0102, DQB1* 0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol, 29, 109-14.
DOI
|
15 |
Fan Y, Wang J, Yang Y, et al (2010). Detection and identification of potential biomarkers of breast cancer. J Cancer Res Clin Oncol, 136, 1243-54.
DOI
|
16 |
Ferrari M (2005). Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer, 5, 161-71.
DOI
ScienceOn
|
17 |
Fujita Y, Nakanishi T, Hiramatsu M, et al (2006). Proteomicsbased approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res, 12, 6415-20.
DOI
ScienceOn
|
18 |
Gold L, Ayers D, Bertino J, et al (2010). Aptamer-based multiplexed proteomic technology for biomarker discovery. PloS One, 5, 15004.
DOI
ScienceOn
|
19 |
Goncalves A, Charafe-Jauffret E, Bertucci F, et al (2008). Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes. Mol Cell Proteomics, 7, 1420-33.
DOI
ScienceOn
|
20 |
Gortzak-Uzan L, Ignatchenko A, Evangelou Al, et al (2007). A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J Proteome Res, 7, 339-51.
|
21 |
Boja ES, Rodriguez H (2012). Mass spectrometry based targeted quantitative proteomics: Achieving sensitive and reproducible detection of proteins. Proteomics, 12, 1093-110.
DOI
ScienceOn
|
22 |
Bai Z, Ye Y, Liang B, et al (2011). Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer. Int J Oncol, 38: 375-83.
|
23 |
Cao Y, DePinho RA, Ernst M, Vousden (2011). Cancer research: past, present and future. Nat Rev Cancer, 11, 749-54.
DOI
ScienceOn
|
24 |
Baker ES, Liu T, Petyuk VA, et al (2012). Mass spectrometry for translational proteomics: progress and clinical implications. Genome Med, 4, 1-11.
DOI
ScienceOn
|
25 |
Bhati A, Garg H, Gupta A, et al (2012). Omics of cancer. Asian Pac J Cancer Prev, 13, 4229-33.
DOI
ScienceOn
|
26 |
Brower V (2011). Epigenetics: Unravelling the cancer code. Nature, 471, 12-3.
DOI
ScienceOn
|
27 |
Castronovo V, Kischel P, Guillonneau F, et al (2007). Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method. Proteomics, 7, 1188-96.
DOI
ScienceOn
|
28 |
Chandra H, Reddy PJ, Srivastava S (2011). Protein microarrays and novel detection platforms. Expert Rev Proteomics, 8, 61-79.
DOI
ScienceOn
|
29 |
Chang R, Shoemaker R, Wang W (2011). Systematic search for recipes to generate induced pluripotent stem cells. PLoS Comput Biol, 7, 1002300.
DOI
|
30 |
Coghlin C, Murray GI (2013). Progress in the identification of plasma biomarkers of colorectal cancer. Proteomics, 13 2227-8.
DOI
ScienceOn
|
31 |
Collins BC, Lau TY, O'Connor DP, Hondermarck H (2009). Cancer proteomics-an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine. EMBO reports, 10, 1202-5.
DOI
ScienceOn
|
32 |
Ardekani AM, Akhondi MM, Sadeghi MR (2008). Application of genomic and proteomic technologies to early detection of cancer. Arch Iran Med, 11, 427-34.
|
33 |
Moghanibashi M, Jazii FR, Soheili ZS, et al (2012). Proteomics of a new esophageal cancer cell line established from Persian patient. Gene, 500, 124-33.
DOI
ScienceOn
|
34 |
Moghanibashi M, Rastgar Jazii F, Soheili ZS, et al (2013). Esophageal cancer alters the expression of nuclear pore complex binding protein Hsc70 and eIF5A-1. Funct Integr Genomics, 13, 253-60.
DOI
ScienceOn
|
35 |
Maurer HH (2010). Perspectives of liquid chromatography coupled to low-and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther Drug Monit, 32, 324-7.
DOI
ScienceOn
|
36 |
Mishra A, Verma M (2010). Cancer biomarkers: are we ready for the prime time? Cancers, 2, 190-208.
DOI
ScienceOn
|
37 |
Montazery-Kordy H, Miran-Baygi MH, Moradi MH (2008). A data-mining approach to biomarker identification from protein profiles using discrete stationary wavelet transform. J Zhejiang Univ Sci B, 9, 863-70.
DOI
ScienceOn
|
38 |
Nezami Ranjbar MR, Zhao Y, Tadesse MG, Wang Y, Ressom HW (2013) Gaussian process regression model for mormalization of LC-MS data using scan-level information. Proteome Sci, 11, 13.
DOI
ScienceOn
|
39 |
Nicolini C, Pechkova E (2010). An overview of nanotechnologybased functional proteomics for cancer and cell cycle progression. Anticancer Res, 30, 2073-80.
|
40 |
Orvisky ES, Drake K, Martin BM, et al (2006). Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics, 6, 2895-902.
DOI
ScienceOn
|
41 |
Karimi P, Modarresi SZ, Sahraian MA, et al (2013). The relation of multiple sclerosis with allergy and atopy: a case control study. Iran J Allergy Asthma Immunol, 12, 182-9.
|
42 |
Kent W J, Sugnet CW, Furey TS, et al (2002). The human genome browser at UCSC. Genome Res, 12, 996-1006.
DOI
|
43 |
Jazii FR, Najafi Z, Malekzadeh R, et al (2006). Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J Gastroenterol, 12, 7104-12.
|
44 |
Kamangar F, Karimi P (2013). The state of nutritional epidemiology: why we are still unsure of what we should eat?. Arch Iran Med, 16, 483-6.
|
45 |
Karimi P, Shahrokni A, Moradi S (2013). Evidence for U.S. Preventive Services Task Force (USPSTF) Recommendations against routine mammography for females between 40-49 years of age. Asian Pac J Cancer Prev, 14, 2137-9.
DOI
ScienceOn
|
46 |
Kocevar N, Odreman F, Vindigni A, Grazio SF, Komel R (2012). Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol, 18, 1216-28.
DOI
ScienceOn
|
47 |
Li G, Xiao Z, Liu J, et al (2011). Cancer: a proteomic disease. Sci China Life Sci, 54, 403-8.
|
48 |
Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002). Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem, 48, 1296-304.
|
49 |
Lopez E, Wesselink JJ, Lopez I, et al (2011). Technical phosphoproteomic and bioinformatic tools useful in cancer research. J Clin Bioinforma, 1, 26.
DOI
ScienceOn
|
50 |
Uemura N, Nakanishi Y, Kato H, et al (2009). Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer, 124, 2106-15.
DOI
ScienceOn
|
51 |
Thiviyanathan V, Gorenstein DG (2012). Aptamers and the next generation of diagnostic reagents. Proteomics Clin Appl, 6, 563-73.
DOI
|
52 |
Yanagisawa K, Tomida S Shimada Y, et al (2007). A 25-Signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst, 99, 858-67.
DOI
ScienceOn
|
53 |
Yousefi Z, Sarvari J, Nakamura K, et al (2012). Secretomic analysis of large cell lung cancer cell lines using two-dimensional gel electrophoresis coupled to mass spectrometry. Folia Histochem Cytobiol, 50, 368-74.
DOI
|
54 |
Tan HT, Lee YH, Chung MC (2012). Cancer proteomics. Mass Spectrom Rev, 31, 583-605.
DOI
ScienceOn
|
55 |
Varghese RS, Zhou B, Nezami Ranjbar MR, Zhao Y, Resson HW (2012). Ion annotation-assisted analysis of LC-MS based metabolomic experiment. Proteome Sci, 21, 1477-5956.
|
56 |
Walther TC, Mann M (2010). Mass spectrometry-based proteomics in cell biology. J Cell Biol, 190, 491-500.
DOI
ScienceOn
|
57 |
Wang J-J, Liu Y, Zheng Y (2012). Comparative proteomics analysis of colorectal cancer. Asian Pac J Cancer Prev, 13, 1663-6.
DOI
ScienceOn
|
58 |
Wang P, Whiteaker JR, Paulovich AG (2009). The evolving role of mass spectrometry in cancer biomarker discovery. Cancer Biol Ther, 8, 1083-94.
|
59 |
Wu CC, Chen HC, Chen SJ, et al (2008). Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics, 8, 316-32.
DOI
ScienceOn
|
60 |
Wulfkuhle JD, Liotta LA, Petriccoin EF (2003). Proteomic applications for the early detection of cancer. Nat Rev Cancer, 3, 267-75.
DOI
ScienceOn
|
61 |
Sadat Tabatabaei Mirakabad F, Nejati-Koshki K, Akbarzadeh A, et al (2014) PLGA-Based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev, 15, 517-35.
DOI
ScienceOn
|
62 |
Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF 3rd, Liotta L (2003). Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol, 532, 59-68.
DOI
|
63 |
Xiao JF, Varghese RS, Zhou B, et al (2012). LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian Cohort. J Proteome Res, 11, 5914-23.
|
64 |
Smith RA, Cokkinides V, von Wschenbach AC, et al (2002). American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin, 52, 8-22.
DOI
ScienceOn
|
65 |
Shahrokni A, Karimi P (2012). Geriatric assessment in geriatric oncology; the evolution of authors' network from 2000 to 2012. J Geriatr Oncol, 3, 78-9.
|
66 |
Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
DOI
ScienceOn
|
67 |
Sousa JF, Ham AJ, Whitwell C, et al (2012). Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Am J Pathol, 181, 1560-72.
DOI
ScienceOn
|
68 |
Paul D, Kumar A, Gajbhiye A, Santra MK, Srikanth R (2013). Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. Biomed Res Int, 2013, 783131.
|
69 |
Srinivas PR, Verma M, Zhao Y, Srivastava S (2002). Proteomics for cancer biomarker discovery. Clin Chem, 48, 1160-9.
|
70 |
Stoevesandt O, Taussig MJ, He M (2009). Protein microarrays: high-throughput tools for proteomics. Expert Rev Proteomics, 6, 145-57.
DOI
ScienceOn
|
71 |
Pei H, Zhu H, Zeng S, et al (2007). Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res, 6, 2495-501.
DOI
ScienceOn
|
72 |
Strassberger V, Fugmann T, Neri D, Roesli C (2010). Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer. J Proteomics, 73, 1954-73.
DOI
ScienceOn
|
73 |
Sun W, Xing B, Sun Y, et al (2007). Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics, 6, 1798-808.
DOI
ScienceOn
|
74 |
Rahman SM, Gonzalez AL Li M, et al (2011). Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Res, 71, 3009-17.
DOI
ScienceOn
|
75 |
Pepe MS, Etzioni R, Feng Z, et al (2001). Phases of biomarker development for early detection of cancer. J Natl Cancer Inst, 93, 1054-61.
DOI
ScienceOn
|
76 |
Ransohoff DF, Gourlay ML (2010). Sources of bias in specimens for research about molecular markers for cancer. J Clin Oncol, 28, 698-704.
DOI
ScienceOn
|
77 |
Ray S, Reddy PJ, Jain R, et al (2011). Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics, 11, 2139-61.
DOI
ScienceOn
|
78 |
Ressom HW, Xiao JF Tuli L, et al (2012). Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Anal Chim Acta, 19, 90-100.
|
79 |
Rezaee AR, Azadi A, Houshmand M, et al (2013). Mitochondrial and nuclear genes as the cause of complex I deficiency. Genet Mol Res, 12, 3551-4.
DOI
|
80 |
Rual JF, Venkatesan K, Hao T, et al (2005). Towards a proteomescale map of the human protein-protein interaction network. Nature, 437, 1173-8.
DOI
ScienceOn
|
81 |
Rusling JF, Kumar CV, Gutkind JS, et al (2010). Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst, 135, 2496-511.
DOI
ScienceOn
|
82 |
Poste G (2012). Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards. Trends Mol Med, 18, 717-22.
DOI
ScienceOn
|
83 |
Martin KJ, Fournier MV, Reddy GP, Pardee AB (2010). A need for basic research on fluid-based early detection biomarkers. Cancer Res, 70, 5203-6.
DOI
ScienceOn
|
84 |
Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014). Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev, In Press.
|
85 |
Yang F, Xiao ZQ, Zhang XZ, et al (2007). Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Proteome Res, 6, 751-8.
DOI
ScienceOn
|